| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.5 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.5 |